Scientists at The Hospital for Sick Children (SickKids) have identified a key gene that could lead to next-generation treatments for medulloblastoma, the most common malignant brain tumor in children.

If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

Revolutionary medical treatments offer new hope for chronic pain sufferers through advanced technology, targeted medications ...

Limited to estrogen receptor-positive breast cancer (ER+) the compound addresses many common concerns with existing treatment ...

The FDA has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta.